NO983135L - Farmasaaytisk preparat - Google Patents

Farmasaaytisk preparat

Info

Publication number
NO983135L
NO983135L NO983135A NO983135A NO983135L NO 983135 L NO983135 L NO 983135L NO 983135 A NO983135 A NO 983135A NO 983135 A NO983135 A NO 983135A NO 983135 L NO983135 L NO 983135L
Authority
NO
Norway
Prior art keywords
tissue
pharmaceutical preparation
physiologically
preparation
injectable
Prior art date
Application number
NO983135A
Other languages
English (en)
Inventor
Malte Kelm
Original Assignee
Sanol Arznei Schwarz Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1996104361 external-priority patent/DE19604361C2/de
Application filed by Sanol Arznei Schwarz Gmbh filed Critical Sanol Arznei Schwarz Gmbh
Publication of NO983135L publication Critical patent/NO983135L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G01N33/4925—Blood measuring blood gas content, e.g. O2, CO2, HCO3

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Ecology (AREA)
  • Biophysics (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

En farmasøytisk blanding i form av en steril, injiserbar, fysiologisk godtagbar oppløsning med et innhold av nitrogenmonoksyd muliggjør at NO lokalt i hoye doser i vev (f.eks. koronarvev) kan utløse ønskede, lokale, biologiske effekter som relaksasjon av den glatte vevmuskulatur, inhibering av adhesjonen av trombocyter osv., uten at det på grunn av hoye doser skjer noen systemiske bivirkninger, som f.eks. et kritisk trykkfall. Blandingenes fremstilling beskrives. Det beskrives videre en deteksjonsmetode for fysiologisk tilstedeværende NO ved hjelp av hvilken man kan fastlegge en endothelial dysfunksjon ved hjelp av fullblod fra mennesker/pattedyr.
NO983135A 1996-02-07 1998-07-07 Farmasaaytisk preparat NO983135L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1996104361 DE19604361C2 (de) 1996-02-07 1996-02-07 Verwendung gasdichter Primärpackmittel für pharmazeutische Zusammensetzungen
PCT/EP1997/000482 WO1997028810A1 (de) 1996-02-07 1997-02-03 Pharmazeutische zusammensetzung enthaltend stickstoffmonoxid

Publications (1)

Publication Number Publication Date
NO983135L true NO983135L (no) 1998-07-07

Family

ID=7784707

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983135A NO983135L (no) 1996-02-07 1998-07-07 Farmasaaytisk preparat

Country Status (10)

Country Link
US (1) US6103769A (no)
EP (2) EP0938324A1 (no)
JP (1) JPH11507948A (no)
KR (1) KR100298228B1 (no)
CN (1) CN1126549C (no)
CA (1) CA2244454C (no)
DE (1) DE19654895C2 (no)
HK (1) HK1045640A1 (no)
NO (1) NO983135L (no)
WO (1) WO1997028810A1 (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19854808C2 (de) * 1998-11-27 2001-03-01 Sanol Arznei Schwarz Gmbh Detektionsverfahren
WO2001017528A1 (en) * 1999-09-08 2001-03-15 Nitromed, Inc. Methods of treating and preventing congestive heart failure with hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate
US7537785B2 (en) * 1999-10-29 2009-05-26 Nitromed, Inc. Composition for treating vascular diseases characterized by nitric oxide insufficiency
AU780261B2 (en) 1999-10-29 2005-03-10 Nitromed, Inc. Methods of treating vascular diseases characterized by nitric oxide insufficiency
US7235237B2 (en) * 1999-10-29 2007-06-26 Nitromed, Inc. Methods of treating vascular diseases characterized by nitric oxide insufficiency
US7708989B2 (en) * 1999-10-29 2010-05-04 Nitromed, Inc. Methods of treating vascular diseases characterized by nitric oxide insufficiency
US20050107738A1 (en) * 2000-07-21 2005-05-19 Slater Charles R. Occludable intravascular catheter for drug delivery and method of using the same
US20050113798A1 (en) * 2000-07-21 2005-05-26 Slater Charles R. Methods and apparatus for treating the interior of a blood vessel
US20030120256A1 (en) * 2001-07-03 2003-06-26 Syntheon, Llc Methods and apparatus for sclerosing the wall of a varicose vein
US7077836B2 (en) * 2000-07-21 2006-07-18 Vein Rx, Inc. Methods and apparatus for sclerosing the wall of a varicose vein
US6432077B1 (en) * 2000-12-26 2002-08-13 Sensormedics Corporation Device and method for treatment of surface infections with nitric oxide
US20030134332A1 (en) * 2001-11-28 2003-07-17 Boykin Joseph V. Diagnosis of endothelial dysfunction by nitric oxide bioactivity index
US20050244382A9 (en) * 2002-01-11 2005-11-03 Whitlock David R Compositions including ammonia oxidizing bacteria and methods of using same
US8703066B2 (en) * 2004-01-07 2014-04-22 Noxilizer, Inc. Sterilization system and method
US8017074B2 (en) * 2004-01-07 2011-09-13 Noxilizer, Inc. Sterilization system and device
AU2005274763A1 (en) * 2004-07-16 2006-02-23 Nitromed, Inc. Compositions and methods related to heart failure
WO2006023203A1 (en) * 2004-08-19 2006-03-02 Vein Rx, Inc. An occludable intravascular catheter for drug delivery and method of using the same
SE0402221D0 (sv) 2004-09-14 2004-09-14 Aerocrine Ab Treatment of insufficient perfusion
KR20060072734A (ko) * 2004-12-23 2006-06-28 두산인프라코어 주식회사 건설중장비의 압축공기 공급장치
CA2605631A1 (en) * 2005-04-20 2006-10-26 Fred Hutchinson Cancer Research Center Methods, compositions and articles of manufacture for enhancing survivability of cells, tissues, organs, and organisms
WO2007097951A2 (en) * 2006-02-17 2007-08-30 Nitromed, Inc. Methods using hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate
US20080200873A1 (en) * 2007-02-16 2008-08-21 Alejandro Espinosa Methods and Apparatus for Infusing the Interior of a Blood Vessel
US8157747B2 (en) 2008-02-15 2012-04-17 Lary Research & Development, Llc Single-use indicator for a surgical instrument and a surgical instrument incorporating same
EP2517736B1 (en) 2009-02-23 2014-03-26 Noxilizer, Inc. Device for gas sterilization
GB2579240B (en) 2018-11-27 2020-12-16 Attgeno Ab New processes, compositions and medical uses
CN112107595A (zh) * 2019-06-19 2020-12-22 华南理工大学 一种芳基硫酸酯酶和葡萄糖苷醛酸酶抑制剂及其制备方法和应用
GB202007929D0 (en) 2020-05-27 2020-07-08 Attgeno Ab New medical uses

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE123658T1 (de) * 1990-06-15 1995-06-15 Cortrak Medical Inc Vorrichtung zur abgabe von medikamenten.
US5536241A (en) * 1990-12-05 1996-07-16 The General Hospital Corporation Methods and devices for relaxing smooth muscle contractions
US5428070A (en) * 1993-06-11 1995-06-27 The Board Of Trustees Of The Leland Stanford Junior University Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production of activity
JPH07165610A (ja) * 1993-12-15 1995-06-27 Hiroshi Maeda 血圧制御剤
DE4410997A1 (de) * 1994-03-30 1995-10-26 Isis Pharma Gmbh Pharmazeutische Zubereitungen und Arzneistoffe zur Prävention und Behandlung endothelialer Dysfunktionen

Also Published As

Publication number Publication date
HK1045640A1 (zh) 2002-12-06
CN1126549C (zh) 2003-11-05
EP0938324A1 (de) 1999-09-01
CA2244454C (en) 2002-12-10
CN1210468A (zh) 1999-03-10
DE19654895A1 (de) 1997-10-02
JPH11507948A (ja) 1999-07-13
KR100298228B1 (ko) 2001-10-26
DE19654895C2 (de) 2000-07-27
US6103769A (en) 2000-08-15
KR19990082372A (ko) 1999-11-25
EP1121934A1 (de) 2001-08-08
WO1997028810A1 (de) 1997-08-14
CA2244454A1 (en) 1997-08-14

Similar Documents

Publication Publication Date Title
NO983135L (no) Farmasaaytisk preparat
US4929602A (en) Method of inhibiting platelet dependent arterial thrombosis
Fabiato et al. Dependence of the contractile activation of skinned cardiac cells on the sarcomere length
DE60033932T2 (de) Methode und zusammensetzung zur inhibierung von kardiovaskulärer zellproliferation
BR0012022A (pt) Composição adesiva monomérica, e, métodos para usar a composição, e para produzir uma composição adesiva com sabor
EP0804595A4 (no)
AU6281590A (en) Device for irradiating laser beams
BG60102B2 (bg) Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол
Amezcua et al. Prolonged paradoxical effect of aspirin on platelet behaviour and bleeding time in man
ES2045182T3 (es) Substancias fisiologicamente activas, un proceso para la preparacion de las mismas y composiciones farmaceuticas que las contienen.
NO20050245L (no) Fremgangsmate for fremstilling av N-acyl-(epi)K5-amin-o-sulfat-derivater og de derved oppnadde produkter
ES2193233T3 (es) Uso de amiodipina, una sal de la misma o felodipina en combinacion con un inhibidor ace en la fabricacion de un medicamento para el tratamiento de insuficiencia cardiaca conjuntiva no isquemica.
JPH09510736A (ja) ヘパリンをベースとした抗血栓性で非出血性の組成物と、その調製方法と、治療への利用
Demiryurek et al. Pharmacological evidence for the role of mediators in hypoxia-induced vasoconstriction in sheep isolated intrapulmonary artery rings
DE3787477D1 (de) Nasal applizierbares Arzneimittel, Verfahren zu seiner Herstellung und seine Verwendung.
CY1106374T1 (el) Μεθοδος θepαπειας αντικαταστασης ορμονης και μορφη χορηγησης της
Matsuno et al. Multiple inhibition of platelet activation by aurintricarboxylic acid prevents vascular stenosis after endothelial injury in hamster carotid artery
NO980300L (no) Nye höymolekylære humane MP52 proteiner
ATE267843T1 (de) Verfahren zur herstellung von selbstvernetzten hyaluronsäuren und deren derivaten mittels superkritischer anti-lösungsmittel
Reynolds et al. Intradermal study of a new local anaesthetic agent: aptocaine
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
Leung et al. Bone-specific alkaline phosphatase activities in plasma and callus during callotasis in rabbits
Krupski et al. Interruption of vascular thrombosis by bolus anti-platelet glycoprotein IIb/IIIa monoclonal antibodies in baboons
DK0538690T3 (da) Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler
Or et al. Low molecular weight heparin stimulates megakaryocytopoiesis in bone‐marrow transplantation patients

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application